跳至主要内容
临床试验/ISRCTN90031373
ISRCTN90031373已完成1 期

ReaDySpeech for people with dysarthria after stroke: initial clinical testing prior to feasibility study

niversity of Manchester0 个研究点目标入组 12 人开始时间: 2015年2月5日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

  1. 2016 results in https://doi.org/10.1080/2331205X.2016.1257410 (added 24/01/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Inclusion criteria for clinicians: Clinicians will be recruited from 4 North West NHS sites that have already agreed to be involved in both the preliminary testing phase of the study and the future feasibility study. These clinicians will have a stroke caseload.
  • Inclusion criteria for patient participants:
  • 1. Patients with dysarthria as a result of stroke as diagnosed by a speech and language therapist
  • 2. Patients more than 12 weeks post stroke with no upper limit post stroke
  • 3. Patients who are willing to trial the computer based programme ReaDySpeech.
  • 4. Participants will present with dysarthria, willing and able to undertake communication therapy (in clinicians' opinion)
  • 5. Sufficient ability in English to participate in therapy without a translator
  • 6. Medically stable
  • 7. Able to give informed consent to participate

排除标准

  • There is no clinician exclusion criteria.
  • Patient participant exclusion criteria:
  • 1. Patients with cognitive or language difficulties that will prevent them giving informed consent or using a computer
  • 2. Patients with insufficient grasp of English

研究者

发起方
niversity of Manchester

相似试验

ReaDySpeech: clinical testing | 临床试验